Digital Health Europe (DHE) Twinning on severe asthma-kick-off meeting report
- PMID: 34164213
- PMCID: PMC8182538
- DOI: 10.21037/jtd-21-792
Digital Health Europe (DHE) Twinning on severe asthma-kick-off meeting report
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jtd-21-792). The series GARD Section was commissioned by the editorial office without any funding or sponsorship. Dr. JB reports personal fees from Chiesi, Cipla, Hikma, Menarini, Mundipharma, Mylan, Novartis, Sanofi-Aventis, Takeda, Teva, Uriach, other from KYomed-Innov, personal fees from Purina, outside the submitted work. Dr. JAF reports being a partner in a company developing mobile technologies for monitoring airways diseases. Dr. PK reports personal fees from Adamed, personal fees from Berlin Chemie Menarini, personal fees from Boehringer Ingelheim, personal fees from Chiesi, personal fees from Hal Allergy, personal fees from Lekam, personal fees from Novartis, personal fees from Polpharma, personal fees from Astra, outside the submitted work. Dr. RL reports grants and personal fees from GSK, grants and personal fees from AZ, grants and personal fees from Novartis, grants from Chiesi, personal fees from Sanofi, outside the submitted work. Dr. TZ reports personal fees from Bayer Health Care, personal fees from FAES, personal fees from Novartis, personal fees from Henkel, from null, from null, from Novartis, from Henkel, personal fees from AstraZeneca Fee for talk, personal fees from AbbVie Fee for talk, personal fees from ALK Fee for talk, personal fees from Almirall Fee for talk, personal fees from Astellas Fee for talk, personal fees from Bayer Health Care Fee for talk, personal fees from Bencard Fee for talk, personal fees from Berlin Chemie Fee for talk, personal fees from FAES Fee for talk, personal fees from HAL Fee for talk, personal fees from Leti Fee for talk, personal fees from Meda Fee for talk, personal fees from Menarini Fee for talk, personal fees from Merck Fee for talk, personal fees from MSD Fee for talk, personal fees from Novartis Fee for talk, personal fees from Pfizer Fee for talk, personal fees from Sanofi Fee for talk, personal fees from Stallergenes Fee for talk, personal fees from Takeda Fee for talk, personal fees from Teva Fee for talk, personal fees from UCB Fee for talk, personal fees from Henkel Fee for talk, personal fees from Kryolan Fee for talk, personal fees from L'Oréal Fee for talk outside the submitted work. Dr. FSR reports personal fees from Astra-Zeneca, personal fees from Novartis, personal fees from Lusomedicamenta, personal fees from Sanofi, personal fees from GSK outside the submitted work. Dr. IT reports personal fees from Novartis, Boehringer Ingelheim, Astra Zeneca, GSK, grants from GSK Hellas, ELPEN, outside the submitted work. The authors have no other conflicts of interest to declare.
